Amerant Bancorp Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amerant Bancorp Inc. on December 7, 2022. The filing addresses corporate governance changes, specifically the departure of a director and the appointment of a new director to the Board of Directors of the Company and its subsidiary, Amerant Bank, N.A.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Resignation of Orlando D. Ashford: The effective date of Mr. Ashford's resignation from the Board of the Company and the Bank was moved forward from December 31, 2022, to December 8, 2022. This change was due to his acceptance of a new full-time executive position.
- Appointment of Erin D. Knight: The Board appointed Erin D. Knight to fill the vacancy created by Mr. Ashford. Her appointment is effective December 15, 2022, and she will serve until the 2023 Annual Meeting.
- Committee Assignments: Ms. Knight has been designated as an independent director and an "audit committee financial expert." She will serve on the Audit and Compensation and Human Capital committees.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary regarding business performance. No specific risks or contingencies related to operations were disclosed in this report. Ms. Knight's appointment was not pursuant to any arrangement or understanding requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Orlando D. Ashford's resignation is effective December 8, 2022.
- Erin D. Knight's appointment to the Board is effective December 15, 2022.
- Ms. Knight is qualified as an audit committee financial expert and will join the Audit and Compensation committees.
- Ms. Knight will receive standard non-employee director compensation, including annual equity grants in the form of restricted stock units.